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Correlation of X-ray diffraction 
signatures of breast tissue and their 
histopathological classification
Robert M. Moss1, Amany S. Amin2, Chiaki Crews1, Colin A. Purdie3, Lee B. Jordan3,  
Francesco Iacoviello  4, Andrew Evans5, Robert D. Speller1 & Sarah J. Vinnicombe5
This pilot study examines the correlation of X-ray diffraction (XRD) measurements with the 
histopathological analysis of breast tissue. Eight breast cancer samples were investigated. Each sample 
contained a mixture of normal and cancerous tissues. In total, 522 separate XRD measurements were 
made at different locations across the samples (8 in total). The resulting XRD spectra were subjected to 
principal component analysis (PCA) in order to determine if there were any distinguishing features that 
could be used to identify different tissue components. 99.0% of the variation between the spectra were 
described by the first two principal components (PC). Comparing the location of points in PC space with 
the classification determined by histopathology indicated correlation between the shape/magnitude of 
the XRD spectra and the tissue type. These results are encouraging and suggest that XRD could be used 
for the intraoperative or postoperative classification of bulk tissue samples.
Breast cancer is the most common form of cancer in the UK with around 55,000 cases diagnosed each year1. 
Research has highlighted the importance of tumour-associated stroma in breast cancer initiation and progression2. 
A major component of such stroma is abnormal collagen, the amount and orientation of which can directly influ-
ence epithelial growth and transition as well as response to neoadjuvant therapy3,4. However, conventional X-ray 
imaging is unable to interrogate the nature of stromal collagen since there is little or no contrast between the 
X-ray attenuation properties of normal and abnormal collagen. Development of a technique that could identify 
abnormal collagen could have a profound impact on breast cancer diagnosis and treatment.
Early breast cancer treatment usually involves breast conserving surgery (BCS) where the cancerous tissue 
is removed from the patient. Histopathological analysis is carried out on the excised tissue postoperatively. The 
tissue is prepared for microscopic analysis starting with dissection of the fresh sample, chemical fixation to pre-
vent decay, further dissection and sampling of regions of interest, processing of the tissue into paraffin wax and 
production of stained microscope slides. The purpose of the analysis is to classify the tumour and to ensure that 
all of the malignancy has been removed. Where cancerous tissue is found at the margins of the resected tissue, the 
patient may be required to undergo further surgery.
Conventional histopathological analysis relies on examining a thin (4 µm thick) slice of tissue based on its 
micro-structure (cellular scale) through the use of optical microscopy. However, changes in the nano-scale struc-
ture associated with disease5 can also be used to discriminate between different tissue types, suggesting that 
X-ray scattering techniques, such as Small Angle X-ray Scattering (SAXS)6–8 and X-ray diffraction (XRD)9–11 are 
suitable for this purpose.
XRD is a well-established technique which is used to analyse the atomic or molecular structure of materials. 
When X-rays interact with matter they can be scattered by the electrons in the constituent atoms. If the resultant 
(or scattered) X-ray has the same phase and energy as the initial X-ray then it is said to have scattered coher-
ently. Diffraction occurs when X-rays are scattered coherently from different atomic or molecular layers within a 
material separated by a distance (d). The results is constructive interfere at certain angles (2θ), where Bragg’s Law 
(Equation (1)) is satisfied, giving rise to intense cones of radiation.
1Department of Medical Physics and Biomedical Engineering, University College London, Gower Street, London, 
WC1E 6BT, UK. 2Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, E1 1BB, UK. 3NHS 
Tayside Pathology Department, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. 4Department 
of Chemical Engineering, University College London, Gower Street, London, WC1E 6BT, UK. 5Division of Cancer 
Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. Correspondence 
and requests for materials should be addressed to R.M.M. (email: robert.moss@ucl.ac.uk)
Received: 5 May 2017
Accepted: 25 September 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCiENtifiC REPORTS | 7: 12998  | DOI:10.1038/s41598-017-13399-9
d2 sin (1)λ θ=
In this study the XRD data were collected using the pixellated diffraction (PixD) method12. The technique 
utilises a multi-element (pixellated) energy-dispersive detector. A histogram is recorded in each pixel based on 
the energies of the photons received. Provided that the scattering geometry (source, sample and detector configu-
ration) is well-defined, each pixel can be assigned a fixed scattering angle (2θ) such that the energy (E) histograms 
can be converted into momentum transfer (x) histograms via Equation (2), where hc = 1.24 keV nm in convenient 
units, allowing the counts in all pixels to be summed together to give a single diffraction pattern. In this case x has 
units of nm−1. A schematic representation of the experimental setup is shown in Fig. 1a.
θ=x E
hc
sin (2)
Since X-rays are penetrating radiation they can be used to look at thick sections of tissue and hence could be 
used to enhance the conventional X-ray absorption imagery (e.g. mammography)13–16. Furthermore, compared 
to histopathological analysis, X-ray diffraction measurements are fast. PixD is a recent development in X-ray dif-
fraction technology which allows diffraction signatures to be obtained with a small compact instrument in 10 s to 
100 s of seconds17. Thus in-theatre analysis of resected tissue could be undertaken to look for involved (positive) 
margins.
Tissue which is mainly composed of fat has a sharp peak at ~1.1 nm−1. As the concentration of fibrous and 
connective tissue increases the intensity of the fat peak reduces and a new feature emerges at ~1.5 nm−1. The 
new feature is typically lower in intensity and broader than the fat peak, indicating that it is associated with less 
ordered tissues, in agreement with the findings of other authors10,18. The purpose of this study is not to investigate 
the shapes of individual structures within breast tissue. The aim is to look for correlations between the shapes 
Figure 1. (a) Schematic representation of the miniPixD instrument. Part of the X-ray source is divided into two 
parts: a fan beam (upper portion) for transmission imaging and a narrow pencil beam (lower portion) for X-ray 
diffraction (XRD). Inset shows beam centre position defined based on diffraction rings cast on the HEXITEC 
detector. (b) Expanded view of the sample and detector showing the scattering geometry for an arbitrary pixel 
in the HEXITEC detector.
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of the XRD pattern measured from a bulk sample (which is assumed to contain a mixture of structure) with the 
histology of the same sample.
Alternative X-ray scattering based technologies currently being investigated for tissue classification include 
coded aperture coherent scatter imaging19,20 and diffraction enhanced CT21–23. This paper looks at the correlation 
between histopathological analysis and X-ray diffraction signatures for a range of breast tissue samples as a step 
towards establishing the viability of diffraction signature analysis for classifying tissue samples.
Results
A series of eight tissue samples were selected which were known to contain tumorous tissue, healthy/normal 
breast tissue and fat. Two tissue specimens are shown in Fig. 2a and b. The tissue was fixed in formalin which is 
known to have negligible effect on XRD measurements10,20. The dark green/grey edge is the ink applied to the sur-
gical margin of the excised tissue prior to sectioning. The yellow tissue is fat and the white regions are dense tissue 
which includes normal/healthy breast tissue and/or carcinoma. Darker brown areas result from haemorrhage 
(due to preoperative diagnostic biopsy) or necrosis occurring at the centre of a tumour24. XRD measurements 
were taken at known positions across each sample (see Methods sections for further details). Principal compo-
nent analysis (PCA) was applied to the diffraction measurements to classify the shapes of the scattering patterns. 
The samples then underwent histopathological analysis and the results were compared with the PCA classification 
of the XRD data.
X-ray measurements were made using the miniPixD instrument17 which has the capability to collect transmis-
sion X-ray images and XRD data of small samples. In this case the miniPixD images were simply used to define 
the sample position. The tissue samples were typically 30 × 25 × 5 mm in size. They were packaged in thin, sealed 
polythene bags, mounted on a sample holder and transmission X-ray images were captured. The images were 
used to define the tissue boundary and the positions to collect XRD measurements were automatically assigned 
(see Methods section for further details). XRD measurements were taken in transmission configuration (i.e. 
through the tissue and the containing bag). Measurements were also made of the polythene bag (without the sam-
ple) to assess the contribution of the bag to the overall scattering profile. Processing the PixD XRD data assumes 
that each pixel in the detector array has a single and well-defined scattering angle. This assumption holds true 
provided that the sample is relatively thin. As the sample becomes thicker, the lack of detector-side collimation 
means that the range of scattering angles each pixel can see becomes larger, having the effect of washing out the 
diffraction features. In this case the scattering angle and associated uncertainty has been calculated for the centre 
pixel as 5.83 ° [+0.42 °, −0.40 °], assuming the sample has a thickness of 5 mm (see Methods for further details).
PCA was performed on the full set of diffraction data from all samples combined. The spectrum of the poly-
thene bag was subtracted from the tissue diffraction patterns as a background. However, it should be noted that 
removal of a constant value from all spectra had no effect on the PCA, which is only sensitive to differences. A 
window was applied in momentum transfer to restrict analysis to a region of interest between 0.7 and 3.0 nm−1. 
Features outside this range are related to the X-ray source properties (e.g. tungsten characteristic lines). It is also 
useful to impose a lower limit on momentum transfer to negate small variations in sample attenuation. Since it is 
low energy photons that contribute to low momentum transfer (at the scattering angles used here), small changes 
in sample thickness and composition can have significant effects on the magnitude of the signal in this region. 
This, in turn, can bias the PCA and smaller variations in spectral shape, due to real changes in the diffraction 
properties of the material, might be missed. Other than background subtraction, the spectra were not normalised 
or corrected for attenuation or spectral shape prior to PCA analysis since the factors would be the same across 
the samples measured.
PCA showed that 99.0% of the variation between spectra could be described by the first two principal compo-
nents (PC1 and PC2, 67.7% and 31.3% respectively). The spread of measurements with respect to PC1 and PC2 
are shown in Fig. 3. It can be seen that the diffraction measurements of the breast tissue samples form a contin-
uum with no distinct groups or clusters developing. This can be explained in terms of the samples being mixed 
specimens. XRD is an additive technique, meaning that the measured diffraction pattern of a mixed sample is 
a combination of the diffraction patterns of the individual components of the mixture. In this case a gradual 
transition from one material type to another would be expected in PC space for an ever changing composition of 
normal, fatty and cancerous tissue.
The loading plots in Fig. 4a can be used to gain some insight into what the PCs are describing. Loadings 
describe the relationship between the original variable space and the PC space; linear combinations of these 
loading coefficients applied to unit vectors along each original axis results in a particular PC. They can therefore 
be used to identify diagnostic momentum transfer values which contribute to a particular PC. In this instance, 
the strong peak at 1.1 nm−1 for the PC1 loadings indicates that the spectra with more positive PC1 scores in Fig. 3 
have this peak present. Similarly, the peak at 1.5 nm−1 in the PC2 loadings indicates that those spectra in Fig. 3 
with more positive PC2 scores display this particular feature. This is demonstrated in Fig. 4b where the spectra 
with the maximum PC1 score and maximum PC2 score are plotted. As expected these exhibits strong features in 
the regions predicted by the loading plots.
In order to understand this distribution, the PCA results were compared to high resolution radiographs taken 
on a clinical mammography system (see Methods section for further details). For each sample the clinical mam-
mography image and the miniPixD image were registered. Landmarks (distinctive features such as edges and 
corners) were identified in each image and a transformation matrix was calculated in Matlab. The transforma-
tion matrix was then used to map the XRD measurement positions onto the mammography images using a 2D 
projective geometric transform. To relate the XRD results to the histology of the samples, the points were colour 
coded based on their PC space coordinates. The coordinates were used to define the hue (H, Equation (3)) and 
the colour saturation (S, Equation (4)) on the HSV scale. A constant value (V = 1) was used for all measurements. 
www.nature.com/scientificreports/
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It should be noted that the arguments contained in square brackets in Equations (3) and (4) were normalised to 
have values between 0 and 1.
= − . × −H PC PC1 0 9[ 1 (1 2)] (3)
S PC PC0 25 0 75[ 1 2] (4)= . + . ×
Figure 2. Comparison of two indicative samples showing (a,b) photographs of the samples as prepared, (c,d) 
colour-coded (based on principal component analysis (PCA) output) diffraction results overlaid on high 
resolution clinical mammography transmission X-ray images and (e,f) digital microscope images of a single 
slice through each sample. The boundaries demarcate the invasive tumour, normal breast tissue and fat as 
yellow, blue/green and red respectively in e and pink, yellow and blue respectvely in f.
www.nature.com/scientificreports/
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The results of the colour coding is shown in Fig. 3 in PC space. The same colours were used to identify the 
PCA classification of the XRD with respect to the measured positions on the samples as shown in Fig. 2c,d.
After the XRD measurements were made, the samples were processed into paraffin wax, sectioned at 4 µm, 
mounted on glass slides and stained with haematoxylin and eosin. Digital micrographs were annotated and 
boundaries drawn around each tissue type present (e.g. carcinoma, normal breast tissue and fat). Examples are 
shown in Fig. 2e,f which can be compared to PCA classifications in Fig. 2c,d respectively.
Discussion
The ability to identify the presence of cancerous tissue in a bulk sample could be transformative for the diagno-
sis and treatment of breast and other cancers. The results presented here are encouraging since we have shown, 
through the application of PCA, that there is correlation between XRD and histological results. This is illustrated 
in Fig. 2. In some samples (e.g. Figure 2c) the transition from one tissue type to another is clear and is supported 
by the transmission X-ray image. In other samples (e.g. Figure 2d) the transition between tissue types is not so 
well defined and picking the tumour boundary in the transmission image is more difficult. It should be noted 
that the micrograph (Fig. 2e,f) corresponds to a thin layer (a few μm thick) through the sample, whereas the XRD 
measurements were made through the entire sample (a few mm thick), meaning that the histology shows only 
Figure 3. Principal component analysis (PCA) results based on the diffraction data (522 spectra) plotted with 
respect to PC1 and PC2. All positions within the samples that were identified as tumorous by histology are 
contained within the bounded region.
Figure 4. (a) Loading plots for PC1 (solid) and PC2 (dashed) and (b) X-ray diffraction (XRD) spectra having 
maximum PC1 score (solid) and maximum PC2 score (dashed).
www.nature.com/scientificreports/
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a fraction of what was actually interrogated by XRD. In order to demonstrate this, a μCT image of the sample 
shown in the right hand column of Fig. 2 is presented in Fig. 5. Figure 5a is a reconstructed slice at approximately 
the same depth as the pathology slide in Fig. 2f. High and low CT values are associated with higher density (nor-
mal tissues and tumour) and lower density (fat) tissues respectively. Figure 5b is an orthogonal slice through the 
sample along the line indicated in Fig. 4a. It can be seen that, even within a sample of a few mm in thickness, the 
tumour boundary shifts in depth such that the XRD would not see a ‘hard boundary’ as the pathology slide sug-
gests. It can also be seen that the tissue type can vary significantly with the normal tissue being composed of dense 
areas (of stroma with or without glandular tissue) interspersed with pockets of fat. This supports the concept of 
tissue mixing being responsible for the spread of results observed in Fig. 3. It was also observed that the tumorous 
tissue (left side of Fig. 5b) is fat deficient compared to the surrounding normal tissue – a characteristic which has 
been reported by other authors10.
The pathology results for all eight tissue samples were compared to the XRD results. Any measured positions 
that fell within the boundaries indicated as invasive tumours by the pathologist were correctly identified by the 
colour-coded PC space plot (Fig. 3). It can be seen that these points are confined to the upper left portion of the 
plot within the indicated boundary. This gives confidence that XRD offers capability to indicate the presence of 
cancerous tissue in a bulk sample. While it has not been possible to differentiate tissue types (i.e. carcinoma, nor-
mal breast tissue and fat), the loading plots produced by the PCA analysis suggest that the variation in the data is 
associated with features consistent with these structures.
These results suggest that the shape and intensity of the X-ray scattering pattern can be used to discriminate 
between different breast tissue types which is supported by other X-ray scattering studies of breast tissue7,8. The 
correlation between the PCA analysis of the data and the histology of the samples is in general agreement with 
other published literature where similar comparisons have been made20. Further work is required to determine 
exactly what the important features are within the XRD spectra to make precise tissue type identification a pos-
sibility in the future.
Methods
Tissue samples. Tissue samples were obtained from the Tayside Tissue Bank (TTB), Dundee, UK. 
Permission and ethical approval to use the tissue was given by the Tayside Biorepository (TBR) Access 
Committee (application reference number TR000408). Authorisation for TBR to grant ethical approval 
is delegated from the Local Research Ethics Committee. All work with the tissue was carried out in com-
pliance with all applicable laws, regulations, guidelines and approvals as outlined in the TTB terms and 
conditions.
Eight tissue samples (from four individuals) were acquired. All patients had undergone therapeutic breast 
surgery for treatment of cancers larger than 20 mm in diameter, and all had given informed consent for use of 
their tissues for research purposes. Resected specimens were formalin-fixed according to standard protocol. After 
formalin fixation, samples were selected such that the blocks taken for research purposes included macroscopic 
tumour, the peritumoural boundary and more distant macroscopically normal breast tissue. The blocks measured 
approximately 30 × 25 mm and were up to 5 mm thick. All blocks were sealed in a polythene bag from which 
most air had been removed for easy handling and to preserve their condition.
Image guided X-ray diffraction. Image guided XRD measurements were made using the miniPixD instru-
ment17. The instrument consists of a compact X-ray tube, a sample position system, a transmission X-ray detector 
and a pixellated energy dispersive X-ray detector. The experimental setup is shown schematically in Fig. 1. The 
X-ray tube settings were maintained at 72 kVp and 1.0 mA throughout the measurements. Beam filtration was 
provided by the 120 μm beryllium exit window only. A 2 mm thick lead collimator was place 37 mm from the 
X-ray tube focal spot and was designed to define a pencil beam (through a 0.6 mm pinhole) and a fan beam 
Figure 5. µCT images of a sample viewed (a) in the same orientation as shown in Fig. 2 (right hand column) 
and (b) as an orthogonal slice along the line shown in (a).
www.nature.com/scientificreports/
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(through a 1 mm slot). The pencil beam was further defined by a second 0.6 mm pinhole collimator placed 235 
mm downstream. The fan beam was incident on the linear strip detector (0.2 mm photodiode pixels with Gadox 
scintillator).
The PixD method12 was used to make the XRD measurements. The technique utilises a cadmium telluride 
(CdTe) sensor bump bonded to an advanced application-specific integrated circuit (ASIC) in a square configura-
tion, offering 80 × 80 pixels with a 250 μm pitch25. The detector was biased to −475 V. The bias voltage was cycled 
every 60 s to avoid polarisation of the CdTe sensor. Data were collected with 0.25 keV energy bins in the range of 
0 to 100 keV. A low energy threshold of 5 keV was used to eliminate detector noise. The pixel registers were read 
out at a rate of 1.5 kHz and the data were processed on a frame-by-frame basis. If an X-ray interacts with the CdTe 
sensor near a pixel boundary it is possible that the liberated charge is spread across and recorded by adjacent 
pixels. This effect is called charge sharing and the result is that a single photon event is wrongly recorded as two 
separate, lower energy events26. A correction was applied whereby events demonstrating charge sharing were 
rejected from the analysis.
The XRD data were collected in transmission mode (i.e. through the tissue) for 300 s at each location. The 
incident pencil beam size at the sample was approximately 1 mm diameter such that the volume interrogated per 
measurement was approximately 4 mm3 (cross-sectional area of the beam multiplied by the sample thickness) in 
this case. The distance between the second beam shaping collimator and the sample position was measured to be 
122 mm and the beam divergence was calculated geometrically to be 0.2 °. The pixellated sensor was position such 
that the primary pencil beam just passed one corner of the detector which measured scatter for angles between 
0.1 ° and 11.2 °. A generalised schematic of the scattering geometry is given in Fig. 1b. A conical X-ray beam is 
incident on a sample of thickness 2 T. The beam has a divergence angle 2ϕ and a diameter 2r at the centre of the 
sample. An arbitrary pixel is located distance D from the centre of the sample and distance d from the beam 
central axis. In the data processing the nominal scattering angle (2θnom) of each pixel is used in the conversion 
to momentum transfer space via Equation 2. In reality a pixel records photons from a range of scattering angles 
between 2θmin and 2θmax. Equations (5–7) are derived from the geometry in Fig. 1b and can be used to calculate 
the scattering angle uncertainty for an arbitrary pixel.
θ = d
D
tan2 (5)nom
d r T
D T
tan(2 ) tan
(6)min
θ ϕ ϕ+ = − +
+
d r T
D T
tan(2 ) tan (7)maxθ ϕ
ϕ
− =
+ +
−
By way of example, consider the current experimental setup and the pixel located at the centre of the detector 
such that d = 14.1 mm, D = 138 mm, 2T = 5 mm, 2r = 1 mm and 2ϕ = 0.2 °. The scattering angles derived from 
Equations (5–7) are, 2θnom = 5.83 °, 2θmin = 5.43 ° and 2θmax = 6.25 °, thus giving this pixel a scattering angle of 
5.83 ° [+0.42 °, −0.40 °]. The uncertainty in scattering angle, and in the detector energy resolution, determines the 
uncertainty in momentum transfer. The energy resolution of the detector used here has been measured previously 
to be 1.6 keV at 60 keV (FWHM)17. By Equation 2, the nominal momentum transfer value for a 60 keV photon 
received at the centre pixel (as described above) would be 2.46 nm−1. The bounds of the momentum transfer value 
can also be calculated using the upper and lower energy and scattering angle values. The worst case upper and 
lower momentum transfer values are 2.26 nm−1 and 2.67 nm−1 respectively.
The system was calibrated to determine the sample to detector distance and the position of the beam centre 
with respect to the pixels. Accurate knowledge of these parameters is essential for obtaining accurate results. A 3 
mm thick sample of caffeine was used for calibration. The caffeine was placed at the same location on the sample 
stage as the tissue specimens and diffraction data were collected. An image was formed by taking a narrow energy 
slice from the detector data which shows one of the diffraction rings. The beam centre was determined by fitting 
a circle through the diffraction ring (see Fig. 1a). The diffraction pattern of caffeine has two prominent peaks at 
0.67 and 1.47 nm−1. The sample to detector distance was adjusted iteratively to match the peaks to the known 
positions. The optimal beam centre position and sample to detector distance were used to analyse the tissue 
sample data.
Clinical mammography imaging. High resolution transmission X-ray images were acquired using a 
Selenia Dimensions (Hologic, Inc.) clinical mammography unit set at 26 kV, a target and filter combination of 
tungsten and rhodium respectively and a magnification of 1.8. The mA and exposure time were selected by the 
system, operating under the automatic exposure control (AEC) mode of ‘auto-time’. The 4th AEC area was selected 
and the samples positioned accordingly. The Modulation Transfer Function was determined by measuring the 
Edge Response Function. The average resolution was found to be 10.62 lines mm−1.
μCT imaging. Computed tomography data were acquired using a Nikon XT H 225 micro-CT system (Nikon 
Metrology). The system was operated in reflection configuration with Mo target (40 kVp and 400  μA, 16 W) and 
the X-ray beam was filtered by the way of a 0.25 mm Mo foil. To obtain a good signal-to-noise ratio, a total of 
3176 radiographs were acquired over a 360° sample rotation range with an exposure time of 1 s per projection. 
The sample was placed between the X-ray source and an amorphous silicon detector (PerkinElmer 1620 detector, 
2000 × 2000 pixels at 200 μm pitch) providing a voxel resolution of ~23.9 μm at a geometric magnification of 8.37.
www.nature.com/scientificreports/
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Histopathology analysis. Histopathology was conducted on the samples after the XRD measurements 
were taken. Following the acquisition of the XRD data, the samples were processed into paraffin wax using stand-
ard techniques, sectioned on a microtome at 4 µm, mounted on a glass microscope slide and stained with haema-
toxylin and eosin (the standard stains for diagnostic microscopy). An Aperio ScanScope XT microscope (Leica 
Biosystems) was used to capture high resolution images.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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